SCHEMBL24511684

SCHEMBL24511684

CC1C[C@H](NCc2ccccc2)CC[C@@H]1O

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 4/20 0.54
GRIN2B Q13224 4/20 0.49
MEN1 O00255 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49
ACHE P22303 4/20 0.45
BACE1 P56817 4/20 0.45
BCHE P06276 2/20 0.45
FYN P06241 1/20 0.45
OPRM1 P35372 2/20 0.44
OPRL1 P41146 2/20 0.44
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24511682 1.00 FUCA1 (0.54) FUCA1GRIN2BMEN1RAB9AKMT2A
SCHEMBL24511693 1.00 FUCA1 (0.54) FUCA1GRIN2BMEN1RAB9AKMT2A
SCHEMBL24511683 1.00 FUCA1 (0.54) FUCA1GRIN2BMEN1RAB9AKMT2A
SCHEMBL24511691 1.00 FUCA1 (0.54) FUCA1GRIN2BMEN1RAB9AKMT2A
SCHEMBL1845568 0.80 GRIN2B (0.54) FUCA1GRIN2BMEN1RAB9AKMT2A
SCHEMBL25176271 0.80 TSHR (0.58) FUCA1GRIN2BMEN1RAB9AKMT2A
Methyl Alcohol SCHEMBL27513196 0.79 GRIN2B (0.67) GRIN2BMEN1RAB9AKMT2AACHE
SCHEMBL29809339 0.79 FUCA1 (0.55) FUCA1GRIN2BMEN1RAB9AKMT2A
SCHEMBL28716809 0.78 GRIN2B (0.55) FUCA1GRIN2BMEN1RAB9AKMT2A
SCHEMBL663239 0.77 GRIN2B (0.74) GRIN2BMEN1RAB9AKMT2AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022122876-A1 N-(IMIDAZO[1,2-B]PYRIDAZIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE AND N-(PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE DERIVATIVES AS IRAK4 INHIBITORS FOR THE TREATMENT OF ASTHMA ASTRAZENECA AB (SE) 2022-06-16 WO disclosed